Cerus Corporation (CERS) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Fri February 26th, 2021

- 15:01
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisCerus Corporation (CERS) Q4 2020 Earnings Call TranscriptThe Motley Fool
- 00:52
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisCerus Corporation's (CERS) CEO Obi Greenman on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha

Thu February 11th, 2021

- 13:03
  Press ReleasesCerus Endovascular Receives FDA Breakthrough Device Designation for its Contour Neurovascular System™PR Newswire

Wed December 16th, 2020

- 14:59
  AnalysisCerus Update: Tailwinds Now Include FDA Approval Of Cryoprecipitate ProductSeeking Alpha

Mon November 30th, 2020

- 17:00
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisCerus (CERS) Is Up 2.47% in One Week: What You Should KnowZacks

Fri November 20th, 2020

- 17:00
  RatingAnalysisAll You Need to Know About Cerus (CERS) Rating Upgrade to BuyZacks

Wed November 18th, 2020

- 13:00
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisCerus Faces Pipeline Of Calamities Going Into 2021Seeking Alpha

Fri October 30th, 2020

- 19:30
  EarningsAnalysisCerus Corporation (CERS) Q3 2020 Earnings Call TranscriptThe Motley Fool
- 17:15
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisCerus Corporation 2020 Q3 - Results - Earnings Call PresentationSeeking Alpha
- 02:41
  EarningsAnalysisCerus Corporation (CERS) CEO Obi Greenman on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha

Thu October 29th, 2020

- 22:05
  AnalysisCerus (CERS) Reports Q3 Loss, Tops Revenue EstimatesZacks + 12 more

Fri October 16th, 2020

- 07:29
  AnalysisCerus Inks FDA Contract, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha

Wed August 5th, 2020

- 06:01
  EarningsAnalysisCerus Corporation (CERS) Q2 2020 Earnings Call TranscriptThe Motley Fool
- 02:47
  EarningsAnalysisCerus Corporation (CERS) CEO Obi Greenman on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha

Tue August 4th, 2020

- 21:15
  AnalysisCerus (CERS) Reports Q2 Loss, Tops Revenue EstimatesZacks + 2 more
- 10:03
  Press ReleasesCerus Endovascular and Balt Enter Strategic Distribution Agreement for Innovative Neurovascular Devices to Treat a Range of Intracranial AneurysmsPR Newswire

Tue July 28th, 2020

- 16:33
  EarningsAnalysisCerus (CERS) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks
- 10:03
  Press ReleasesCerus Endovascular Receives CE Mark Approval for its CerusEndo MC 021 MicrocatheterPR Newswire

Wed June 17th, 2020

- 15:30
  AnalysisIs Cerus (CERS) Outperforming Other Medical Stocks This Year?Zacks

Wed May 27th, 2020

- 16:00
  RatingAnalysisCerus (CERS) Upgraded to Buy: What Does It Mean for the Stock?Zacks

SPY$383.33-0.078%

QQQ$301.55-2.3%

DOW$63.460.87%

NIU$30.09-10%

RKT$24.77-1.3%

SPY$383.33-0.078%

QQQ$301.55-2.3%

DOW$63.460.87%

NIU$30.09-10%

RKT$24.77-1.3%

About Developer Contact